NCT07210567 Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors
| NCT ID | NCT07210567 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Rutgers, The State University of New Jersey |
| Condition | Smoking Cessation |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2026-01-27 |
| Primary Completion | 2027-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2026-01-27 with a primary completion date of 2027-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of the study is to develop a new quit-smoking treatment among individuals with a cancer diagnosis using a smartphone app.
Eligibility Criteria
Inclusion Criteria: * ≥18 years old * smoked ≥1 cigarette per day (even one or two puffs) within the past 30 days * having been diagnosed with cancer * being motivated to quit in the next 30 days * having a valid home address and functioning phone number * being able to read, write, and speak English * having a smartphone that allows installation of the app * willingness to download the app Exclusion Criteria: * being enrolled in a smoking cessation program * current use of smoking cessation medications * evidence of current psychosis * current/planning pregnancy or lactation
Contact & Investigator
Min-Jeong Yang, PhD
PRINCIPAL INVESTIGATOR
Rutgers, The State University of New Jersey
Frequently Asked Questions
Who can join the NCT07210567 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking Cessation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07210567 currently recruiting?
Yes, NCT07210567 is actively recruiting participants. Contact the research team at irboffice@research.rutgers.edu for enrollment information.
Where is the NCT07210567 trial being conducted?
This trial is being conducted at New Brunswick, United States.
Who is sponsoring the NCT07210567 clinical trial?
NCT07210567 is sponsored by Rutgers, The State University of New Jersey. The principal investigator is Min-Jeong Yang, PhD at Rutgers, The State University of New Jersey. The trial plans to enroll 50 participants.